Table 2.
Demographic and Clinical Characteristics of Patients With a 30-Day Hospital Revisit After Septorhinoplasty
| Characteristic | Patients, No. |
Patients With Hospital Revisit, No. (%) |
Unadjusted Odds Ratio (99% CI) |
|---|---|---|---|
| Total | 175 842 | 11 456 (6.5) | |
| State | |||
| California | 73 810 | 4958 (6.7) | 1 [Reference] |
| Florida | 51 911 | 3924 (7.6) | 1.14 (0.80–1.61) |
| New York | 50 121 | 2574 (5.1) | 0.75 (0.54–1.05) |
| Age, y | |||
| 13–18 | 10 989 | 472 (4.3) | 0.74 (0.65–0.84) |
| 19–40 | 74 754 | 4284 (5.7) | 1 [Reference] |
| 41–65 | 77 455 | 5302 (6.8) | 1.21 (1.12–1.30) |
| >65 | 12 644 | 1398 (11.1) | 2.05 (1.81–2.31) |
| Sexa | |||
| Male | 99 255 | 6600 (6.6) | 1 [Reference] |
| Female | 69 717 | 4570 (6.6) | 0.99 (0.91–1.07) |
| Raceb | |||
| White | 116 241 | 7838 (6.7) | 1 [Reference] |
| Black | 4147 | 390 (9.4) | 1.43 (1.21–1.69) |
| Hispanic | 17 898 | 1369 (7.6) | 1.15 (0.98–1.34) |
| Asian or Pacific Islander | 4545 | 238 (5.2) | 0.76 (0.61–0.95) |
| Other | 8392 | 473 (5.6) | 0.83 (0.64–1.07) |
| Insurancec | |||
| Medicare | 16 537 | 1908 (11.5) | 2.05 (1.79–2.34) |
| Medicaid | 7128 | 708 (9.9) | 1.73 (1.35–2.22) |
| Private insurance | 131 993 | 7896 (6.0) | 1 [Reference] |
| Self-pay | 12 323 | 416 (3.4) | 0.55 (0.42–0.72) |
| Other | 7772 | 524 (6.7) | 1.14 (0.87–1.48) |
| Patient locationd | |||
| Large metropolitan | 125 678 | 7739 (6.2) | 1 [Reference] |
| Small metropolitan | 41 892 | 3031 (7.2) | 1.90 (1.03–1.37) |
| Micropolitan | 5892 | 488 (8.3) | 1.38 (1.08–1.75) |
| Not metropolitan or micopolitan | 2364 | 198 (8.4) | 1.39 (1.05–1.84) |
| Median household income, percentilee | |||
| 0 to 25th | 16 420 | 1289 (7.9) | f |
| 26th to 50th | 25 987 | 1759 (6.8) | f |
| 51st to 75th | 26 878 | 1747 (6.5) | f |
| 76th to 100th | 30 940 | 1581 (5.1) | f |
| Elixhauser Comorbidity Indexg | |||
| 0 | 173 460 | 11 030 (6.4) | 1 [Reference] |
| 1 | 2379 | 425 (17.9) | 3.20 (2.68–3.82) |
| 2 | <10h | <10h | f |
| 3 | 0 | 0 | f |
| No. of Elixhauser comorbiditiesg | |||
| 0 | 132 315 | 6891 (5.2) | 1 [Reference] |
| 1 | 26 823 | 2338 (8.7) | 1.74 (1.38–2.20) |
| 2 | 10 287 | 1174 (11.4) | 2.35 (1.96–2.80) |
| ≥3 | 6417 | 1053 (16.4) | 3.57 (3.16–4.03) |
| Patient comorbidities | |||
| Diabetes | 5681 | 686 (12.1) | 2.03 (1.77–2.33) |
| Obesity | 5566 | 548 (9.8) | 1.60 (1.38–1.84) |
| Alcohol use | 1148 | 189 (16.5) | 2.86 (2.28–3.58) |
| Drug use | 993 | 172 (17.3) | 3.04 (2.35–3.93) |
| Tobacco use | 13 138 | 1345 (10.2) | 1.72 (1.46–2.03) |
| Anxiety | 4439 | 645 (14.5) | 2.53 (2.16–2.95) |
| Depression | 3691 | 487 (13.2) | 2.23 (1.87–2.68) |
| Autoimmune disorder or immunodeficiency | 1311 | 277 (21.1) | 3.92 (2.09–7.34) |
| Coagulopathy | 367 | 77 (21.0) | 3.83 (2.69–5.44) |
a
Data missing for 6870 patients.
b
Data missing for 24 592 patients.
c
Data missing for 89 patients.
d
Categories are defined in the Outcome Measures subsection of the Methods section. Data missing for 16 patients.
e
Data missing for 75 617 patients.
f
No analysis was performed owing to the high percentage of missing data.
g
Described in Elixhauser et al.15
h
The Healthcare Cost and Utillization Project does not report exact numbers for categories with fewer than 10 patients.